|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2 Pt 1
|
|
pubmed:dateCreated |
1999-3-5
|
|
pubmed:abstractText |
From observational studies, there is evidence that hormone replacement therapy in postmenopausal women causes a decrease in cardiovascular events. It remains unknown, however, precisely by which mechanisms this reduction is achieved. The primary aim of this work was to study the effects of hormone replacement therapy on established hemostatic risk factors during 1-year treatment of healthy postmenopausal women. The secondary aim was to investigate whether there was any significant difference in these risk factors between hormone replacement therapy administered as a cyclic estrogen/sequential progestogen or continuous estrogen/sequential progestogen regimen.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0002-9378
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
180
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
283-9
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9988788-Cardiovascular Diseases,
pubmed-meshheading:9988788-Cyproterone Acetate,
pubmed-meshheading:9988788-Estradiol,
pubmed-meshheading:9988788-Estrogen Replacement Therapy,
pubmed-meshheading:9988788-Factor VII,
pubmed-meshheading:9988788-Female,
pubmed-meshheading:9988788-Fibrinogen,
pubmed-meshheading:9988788-Hemostasis,
pubmed-meshheading:9988788-Humans,
pubmed-meshheading:9988788-Lipoprotein(a),
pubmed-meshheading:9988788-Middle Aged,
pubmed-meshheading:9988788-Placebos,
pubmed-meshheading:9988788-Plasminogen Activator Inhibitor 1,
pubmed-meshheading:9988788-Postmenopause,
pubmed-meshheading:9988788-Risk Factors,
pubmed-meshheading:9988788-Tissue Plasminogen Activator
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Effects of hormone replacement therapy on hemostatic cardiovascular risk factors.
|
|
pubmed:affiliation |
Diabetes Centre, Department of Gynecology and Obstetrics, Rigshospitalet, and the Department of Gynecology and Obstetrics, Frederiksberg Hospital, Copenhagen, Denmark.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
